Correlations of amyloid PET, tau PET and CSF biomarkers with dementia severity as measured by the CDR sum of boxes (CDR-SB) were also examined in the large Knight ADRC amyloid PET cohort (Fig. 1c). Here, MAPT is linked to dementia.